Literature DB >> 19593798

Genetically transforming human mesenchymal stem cells to sarcomas: changes in cellular phenotype and multilineage differentiation potential.

Nan Li1, Rui Yang, Wendong Zhang, Howard Dorfman, Pulivarthi Rao, Richard Gorlick.   

Abstract

BACKGROUND: The cell of origin of sarcoma is still unclear. High-grade osteosarcomas frequently demonstrate the potential for multipotent differentiation and, along with several other lines of evidence, suggest that human mesenchymal stem cells (hMSC) might be the cell of origin.
METHODS: The hMSCs were transformed with retrovirus containing human telomerase reverse transcriptase (hTERT), simian virus 40 large t antigen (SV40 TAg), and lentivirus containing oncogenic H-Ras serially. The changes of cellular phenotypes and multilineage differentiation capacity were observed and compared with the standard osteosarcoma cell lines.
RESULTS: Two distinct genotypic and phenotypic sarcoma cell lines resulted from the same genetic events. The gene expression profiles became more complicated and the karyotype became more chaotic during hMSCs' tumorigenesis. The motility of transformed hMSC was promoted. hMSC and its derivatives could be induced to osteogenic, adipogenic, and chondrogenic differentiation except that MSC-TSR4 lost osteogenic differentiation capacity.
CONCLUSIONS: Multilineage differentiation potential was retained during tumorigenesis of hMSCs and distinct sarcoma cell lines could arise with the same genetic events, providing good models in better understanding the concept of hMSC and in further investigation of the relationship of hMSCs and osteosarcomas. Copyright (c) 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19593798      PMCID: PMC2771660          DOI: 10.1002/cncr.24519

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  31 in total

1.  Spontaneous human adult stem cell transformation.

Authors:  Daniel Rubio; Javier Garcia-Castro; María C Martín; Ricardo de la Fuente; Juan C Cigudosa; Alison C Lloyd; Antonio Bernad
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

2.  Creation of human tumour cells with defined genetic elements.

Authors:  W C Hahn; C M Counter; A S Lundberg; R L Beijersbergen; M W Brooks; R A Weinberg
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

3.  Genetic modeling of human rhabdomyosarcoma.

Authors:  Corinne M Linardic; Diane L Downie; Stephen Qualman; Rex C Bentley; Christopher M Counter
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

4.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

Review 5.  Osteosarcoma.

Authors:  P A Meyers; R Gorlick
Journal:  Pediatr Clin North Am       Date:  1997-08       Impact factor: 3.278

6.  Integration of SV40 in human osteosarcoma DNA.

Authors:  S M Mendoza; T Konishi; C W Miller
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

7.  Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.

Authors:  A Kallioniemi; O P Kallioniemi; D Sudar; D Rutovitz; J W Gray; F Waldman; D Pinkel
Journal:  Science       Date:  1992-10-30       Impact factor: 47.728

8.  Analysis of telomerase activity and telomere length in bone and soft tissue tumors.

Authors:  Tadashi Terasaki; Satoru Kyo; Masahiro Takakura; Yoshiko Maida; Hiroyuki Tsuchiya; Katsuro Tomita; Masaki Inoue
Journal:  Oncol Rep       Date:  2004-06       Impact factor: 3.906

9.  Mutational activation of ras genes is absent in pediatric osteosarcoma.

Authors:  F Antillón-Klüssmann; M García-Delgado; I Villa-Elízaga; L Sierrasesúmaga
Journal:  Cancer Genet Cytogenet       Date:  1995-01

10.  A genetically defined model for human ovarian cancer.

Authors:  Jinsong Liu; Gong Yang; Jennifer A Thompson-Lanza; Armand Glassman; Kimberly Hayes; Andrea Patterson; Rebecca T Marquez; Nelly Auersperg; Yinhua Yu; William C Hahn; Gordon B Mills; Robert C Bast
Journal:  Cancer Res       Date:  2004-03-01       Impact factor: 12.701

View more
  37 in total

Review 1.  Modeling sarcomagenesis using multipotent mesenchymal stem cells.

Authors:  Rene Rodriguez; Ruth Rubio; Pablo Menendez
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

2.  Genetic stability of bone marrow-derived human mesenchymal stromal cells in the Quantum System.

Authors:  Mark Jones; Marileila Varella-Garcia; Margaret Skokan; Steven Bryce; Jeffrey Schowinsky; Rebecca Peters; Boah Vang; Michelle Brecheisen; Thomas Startz; Nathan Frank; Brian Nankervis
Journal:  Cytotherapy       Date:  2013-08-28       Impact factor: 5.414

3.  Evidence for the osteosarcoma stem cell.

Authors:  C Parker Gibbs; Padraic P Levings; Steven C Ghivizzani
Journal:  Curr Orthop Pract       Date:  2011-07

Review 4.  The role of mesenchymal stem/progenitor cells in sarcoma: update and dispute.

Authors:  Jilong Yang; Zhiwu Ren; Xiaoling Du; Mengze Hao; Wenya Zhou
Journal:  Stem Cell Investig       Date:  2014-10-27

5.  Osteosarcoma cells differentiate into phenotypes from all three dermal layers.

Authors:  Scott Russinoff; Sara Miran; Ashok L Gowda; Paul A Lucas
Journal:  Clin Orthop Relat Res       Date:  2011-06-16       Impact factor: 4.176

6.  What is the oncologic risk of stem cell treatment for heart disease?

Authors:  Konstantinos E Hatzistergos; Arnon Blum; Tan Ince; James M Grichnik; Joshua M Hare
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

Review 7.  Immunological applications of stem cells in type 1 diabetes.

Authors:  Paolo Fiorina; Julio Voltarelli; Nicholas Zavazava
Journal:  Endocr Rev       Date:  2011-08-23       Impact factor: 19.871

8.  Mesenchymal stem cell-like cells in classic renal angiomyolipoma.

Authors:  Xinlong Yan; Lixin Shi; Guangfu Chen; Xu Zhang; Bing Liu; Wen Yue; Xuetao Pei; Shengkun Sun
Journal:  Oncol Lett       Date:  2012-06-14       Impact factor: 2.967

9.  Shared cell surface marker expression in mesenchymal stem cells and adult sarcomas.

Authors:  Stefan Wirths; Elke Malenke; Torsten Kluba; Simone Rieger; Martin R Müller; Sabine Schleicher; Claus Hann von Weyhern; Florian Nagl; Falko Fend; Wichard Vogel; Frank Mayer; Lothar Kanz; Hans-Jörg Bühring; Hans-Georg Kopp
Journal:  Stem Cells Transl Med       Date:  2012-12-19       Impact factor: 6.940

10.  Osteosarcoma: mouse models, cell of origin and cancer stem cell.

Authors:  Maria V Guijarro
Journal:  Postdoc J       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.